BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33034918)

  • 1. Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Holmes BJ; von Eyben R; Attardi LD; Kong CS; Le QT; Nathan CO
    Head Neck; 2020 Nov; 42(11):3188-3196. PubMed ID: 33034918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.
    Beaudry VG; Jiang D; Dusek RL; Park EJ; Knezevich S; Ridd K; Vogel H; Bastian BC; Attardi LD
    PLoS Genet; 2010 Oct; 6(10):e1001168. PubMed ID: 20975948
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
    BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse.
    Kong CS; Cao H; Kwok S; Nguyen CM; Jordan RC; Beaudry VG; Attardi LD; Le QT
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jan; 115(1):95-103. PubMed ID: 23217540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
    Roberts O; Paraoan L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
    Abouhashem NS; Elwan A; Elaidy NF
    Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
    Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
    Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ki-67, Cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC).
    Govindaraj PK; Kallarakkal TG; Mohd Zain R; Tilakaratne WM; Lew HL
    PLoS One; 2021; 16(12):e0261575. PubMed ID: 34941961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
    Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
    Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
    Wang X; Chen S; Chen X; Zhang C; Liang X
    J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
    N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck.
    Kanatas A; Harris A
    Tumori; 2008; 94(3):444; author reply 444. PubMed ID: 18705420
    [No Abstract]   [Full Text] [Related]  

  • 17. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.
    Dusek RL; Bascom JL; Vogel H; Baron S; Borowsky AD; Bissell MJ; Attardi LD
    Breast Cancer Res; 2012 Apr; 14(2):R65. PubMed ID: 22515648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins.
    Hum L; Bethmann D; Feng Z; Chang SC; Eckert A; Ballesteros-Merino C; Keschke C; Kappler M; Bifulco CB; Wickenhauser C; Seliger B; Fox BA; Bryan Bell R
    Head Neck; 2021 Feb; 43(2):568-576. PubMed ID: 33094869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.